Computational and structural analysis of deleterious functional SNPs in ARNT oncogene

Interdisciplinary Sciences, Computational Life Sciences
C George Priya Doss, Rao Sethumadhavan

Abstract

Along with the completion of human genome project, major interest in human genetics is to distinguish mutations that are functionally neutral from those that contribute to disease. The central focus of cancer genetics is the study of mutations that are causally implicated in tumorigenesis. The identification of such causal mutations not only provides insight into cancer biology but also presents anticancer therapeutic targets and diagnostic markers. Understanding the human genetic variation through Single Nucleotide Polymorphisms (SNPs) is currently believed to reveal the cause of individual susceptibility to disease and the large variation observed in response to treatment. The aim of our study reported here is to determine the deleterious SNPs that can alter the expression and function of the ARNT gene in causing acute myeloblastic leukemia through computational methods. Our approach will present the application of computational tools in understanding functional variation from the perspective of structure, expression, evolution and phenotype. Based on the SIFT (evolutionary basedapproach) and PolyPhen (structure based-approach) scores, structure analysis was carried out with the major mutation that occurred in the native prot...Continue Reading

References

Nov 8, 1990·The New England Journal of Medicine·T P DryjaE L Berson
Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·H S Chan, K A Dill
Jan 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·A YoshidaM Ikawa
Oct 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·R L Proia, E F Neufeld
Feb 4, 1994·Science·R Nowak
Apr 1, 1994·Current Opinion in Genetics & Development·N Sonenberg
Oct 20, 1994·The New England Journal of Medicine·E P SmithK S Korach
Apr 27, 2000·Trends in Genetics : TIG·S SunyaevP Bork
Apr 29, 2000·Intensive Care Medicine·S J van Deventer
Jun 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·F Salomon-NguyenO A Bernard
Jan 11, 2000·Nucleic Acids Research·S T SherryK Sirotkin
Feb 15, 2001·JAMA : the Journal of the American Medical Association·D M Livingston, R Shivdasani
Mar 7, 2001·Human Molecular Genetics·S SunyaevP Bork
May 5, 2001·Genome Research·P C Ng, S Henikoff
Mar 5, 2002·Genome Research·Pauline C Ng, Steven Henikoff
Aug 31, 2002·Nucleic Acids Research·Vasily RamenskyShamil Sunyaev
Jan 9, 2003·Journal of the American Chemical Society·Stephen J RussellAndrea G Cochran
Jun 26, 2003·Nucleic Acids Research·Pauline C Ng, Steven Henikoff
Feb 24, 2004·Journal of Computational Chemistry·Eran EyalVladimir Sobolev
Apr 13, 2004·The Journal of Pharmacology and Experimental Therapeutics·Eric Y ZhangKathleen M Hillgren
Apr 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Marc Delarue, Philippe Dumas
May 4, 2004·BMC Bioinformatics·Shandar AhmadAkinori Sarai
May 5, 2004·Expert Reviews in Molecular Medicine·Ludmila Prokunina, Marta E Alarcón-Riquelme
Jul 22, 2004·Nature Reviews. Genetics·Timothy R RebbeckXifeng Wu
May 1, 1997·Acta Crystallographica. Section D, Biological Crystallography·G F FabiolaV Pattabhi
Sep 15, 2004·Genome Research·Robert J LivingstonDeborah A Nickerson
May 17, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Melissa M JohnsonChu Chen
Jun 7, 2005·Nucleic Acids Research·Huiling Chen, Huan-Xiang Zhou
Jun 28, 2005·Nucleic Acids Research·Csaba MagyarIstván Simon
Apr 25, 2006·BMC Bioinformatics·Richard J DobsonMansoor As Saqi

❮ Previous
Next ❯

Citations

Aug 11, 2011·Drug Metabolism and Pharmacokinetics·Jonathan D UrbanJ Craig Rowlands
Nov 18, 2014·Journal of Chemical Information and Modeling·Roberto NutiAntonio Macchiarulo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.